2,3,6-tri-O-methyl-1,4,5-tri-O-acetyl-D-mannitol | 53833-81-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2,3,6-tri-O-methyl-1,4,5-tri-O-acetyl-D-mannitol
• 英文别名: 2,3,6-Tri-O-methyl-1,4,5-tri-O-acetyl-D-mannit；1,4,5-Tri-O-acetyl-2,3,6-tri-O-methyl-D-mannit；2,3,6-Tri-O-methyl-mannitol-triacetat；1,4,5-tri-O-acetyl-2,3,6-tri-O-methylmannitol；[(2R,3R,4R,5R)-4,5-diacetyloxy-2,3,6-trimethoxyhexyl] acetate
• CAS: 53833-81-1
• 化学式: C₁₅H₂₆O₉
• 分子量: 350.366
• InChiKey: ATVQUEJOBOKGCC-KBUPBQIOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  24
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  107
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  乙酸酐 、 methylated arabinogalactan from Jasminum sambac (L_.) 生成 1,4-di-O-acetyl-2,3,5-tri-O-methyl-L-arabinitol 、 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl-D-galactitol 、 1,4,5-tri-O-acetyl-2,3-di-O-methyl-L-arabinitol 、 1,5,6-tri-O-acetyl-2,3,4-tri-O-methyl-D-galactitol 、 1,3,5-tri-O-acetyl-2,4,6-tri-O-methylgalactitol 、 2,3,6-tri-O-methyl-1,4,5-tri-O-acetyl-D-mannitol 、 1,3,5,6-tetra-O-acetyl-2,4-di-O-methyl-D-galactitol
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• A PROCESS FOR THE PREPARATION OF POLYMERIC BIOSURFACTANTS
  申请人：Council of Scientific & Industrial Research

  公开号：EP2947153A2

  公开（公告）日：2015-11-25

  The present invention relates to polymeric biosurfactants isolated from two bacterial strains of Microbacterium sp. strain BS-2 [MTCC 5822] and Brevibacillus sp. strain BS-207 [MTCC 5823]. The present invention relates to an acidic exopolysaccharide (EPS), termed Microsan, with chemical composition of glucose, mannose and glucuronic acid (β-D-glucuronyl-(1-2)-D-mannosyl-(1-4)-D-glucose) produced by Microbacterium sp. strain BS-2 and a neutral EPS, termed Brevisan, of galactomannan with galactose and mannose residues in the ratio of 1:1 produced by Brevibacillus sp. strain BS-207. Both these polysaccharides exhibited surface-active and potential antibacterial, antioxidant, anti-inflammatory, and immunomodulatory activities.

  本发明涉及从微杆菌 BS-2 株[MTCC 5822]和芽孢杆菌 BS-207 株[MTCC 5823]两株细菌中分离出来的高分子生物表面活性剂。本发明涉及一种由微细菌菌株 BS-2 产生的酸性外多糖（EPS），称为 Microsan，其化学成分为葡萄糖、甘露糖和葡萄糖醛酸（β-D-葡萄糖醛酸基-(1-2)-D-甘露糖基-(1-4)-D-葡萄糖）；以及一种由乳酸杆菌菌株 BS-207 产生的中性外多糖，称为 Brevisan，其化学成分为半乳甘露聚糖，半乳糖和甘露糖残基的比例为 1:1。这两种多糖都具有表面活性和潜在的抗菌、抗氧化、抗炎和免疫调节活性。
• Process for the preparation of polymeric biosurfactants
  申请人：COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH

  公开号：US10106627B2

  公开（公告）日：2018-10-23

  The present invention relates to polymeric biosurfactants isolated from two bacterial strains of Microbacterium sp. strain BS-2 [MTCC 5822] and Brevibacillus sp. strain BS-207 [MTCC 5823]. The present invention relates to an acidic exopolysaccharide (EPS), termed Microsan, with chemical composition of glucose, mannose and glucuronic acid (β-D-glucuronyl-(1-2)-D-mannosyl-(1-4)-D-glucose) produced by Microbacterium sp. strain BS-2 and a neutral EPS, termed Brevisan, of galactomannan with galactose and mannose residues in the ratio of 1:1 produced by Brevibacillus sp. strain BS-207. Both these polysaccharides exhibited surface-active and potential antibacterial, antioxidant, anti-inflammatory, and immunomodulatory activities.

  本发明涉及从微杆菌 BS-2 株[MTCC 5822]和芽孢杆菌 BS-207 株[MTCC 5823]两株细菌中分离出来的高分子生物表面活性剂。本发明涉及一种由微细菌菌株 BS-2 产生的酸性外多糖（EPS），称为 Microsan，其化学成分为葡萄糖、甘露糖和葡萄糖醛酸（β-D-葡萄糖醛酸基-(1-2)-D-甘露糖基-(1-4)-D-葡萄糖）；以及一种由乳酸杆菌菌株 BS-207 产生的中性外多糖，称为 Brevisan，其化学成分为半乳甘露聚糖，半乳糖和甘露糖残基的比例为 1:1。这两种多糖都具有表面活性和潜在的抗菌、抗氧化、抗炎和免疫调节活性。
• PROCESS FOR THE PREPARATION OF POLYMERIC BIOSURFACTANTS
  申请人：COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH

  公开号：US20150322173A1

  公开（公告）日：2015-11-12

  The present invention relates to polymeric biosurfactants isolated from two bacterial strains of Microbacterium sp. strain BS-2 [MTCC 5822] and Brevibacillus sp. strain BS-207 [MTCC 5823]. The present invention relates to an acidic exopolysaccharide (EPS), termed Microsan, with chemical composition of glucose, mannose and glucuronic acid (β-D-glucuronyl-(1-2)-D-mannosyl-(1-4)-D-glucose) produced by Microbacterium sp. strain BS-2 and a neutral EPS, termed Brevisan, of galactomannan with galactose and mannose residues in the ratio of 1:1 produced by Brevibacillus sp. strain BS-207. Both these polysaccharides exhibited surface-active and potential antibacterial, antioxidant, anti-inflammatory, and immunomodulatory activities.